Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |